All Updates

All Updates

icon
Filter
Partnerships
Paragon Genomics partners with Biosecure ID to distribute CleanPlex products in UK and Ireland
Precision Medicine
Jul 9, 2024
This week:
Partnerships
MGI Tech and Predica Diagnostics collaborate to develop Predica's targeted RNA sequencing tests
Precision Medicine
Jul 11, 2024
Partnerships
Renalytix partners with Steno Diabetes Center to advance precision medicine solutions for diabetes and chronic kidney disease
Precision Medicine
Jul 11, 2024
Partnerships
Myriad Genetics and Personalis cross-license patents for tumor-informed cancer treatment tests
Precision Medicine
Jul 11, 2024
Funding
Element Biosciences raises USD 277 million in Series D funding to commercialize AVITI DNA sequencer and support AVITI24 launch
Precision Medicine
Jul 11, 2024
Funding
Jacobi Robotics raises USD 5 million in seed funding to expand capacity
Smart Factory
Jul 11, 2024
M&A
Formlabs acquires Micronics for undisclosed sum to develop next-generation SLS printers
Additive Manufacturing
Jul 11, 2024
Partnerships
Anthropic partners with Amazon Bedrock to fine-tune Claude 3 Haiku model
Foundation Models
Jul 11, 2024
Funding
Lemon.markets raises EUR 12 million in funding to support growth
FinTech Infrastructure
Jul 11, 2024
M&A
Kipu Quantum acquires PlanQK platform to enhance accessibility to quantum computing solutions
Quantum Computing
Jul 11, 2024
Partnerships
Quantinuum and STFC Hartree Centre partner to enhance quantum computing accessibility in UK
Quantum Computing
Jul 11, 2024
Precision Medicine

Precision Medicine

Jul 9, 2024

Paragon Genomics partners with Biosecure ID to distribute CleanPlex products in UK and Ireland

Partnerships

  • Paragon Genomics has partnered with Biosecure ID to distribute its technology in the UK and Ireland. Biosecure ID is a for-profit unit of Science Social for Good CIC, an organization dedicated to genetic research and testing services.

  • This partnership aims to expand the availability of Paragon's CleanPlex technology in these markets. CleanPlex offers ultra-high multiplexed target enrichment technology for NGS assays for research and diagnostics. The assay is compatible with major sequencing platforms, including Illumina, Ion Torrent, MGI DNBSeq, and Singular Genomics. The product is available in ready-to-use or custom NGS panels. 

  • Paragon Genomics develops and commercializes PCR-based target enrichment solutions for next-generation sequencing (NGS). The company's proprietary CleanPlex technology enables the development of custom and fixed NGS panels for various applications, including oncology, infectious diseases, and genetic disorders. It focuses on providing cost-effective solutions with high sensitivity and is designed to advance precision medicine by supporting genomic profiling and targeted sequencing.​

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.